FDA Investigator Graeme E Price
Graeme E Price has conducted inspections on 7 sites in 2 countries as of 14 Dec 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
14 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Belgium
FDA Investigators that have inspected at least one site in common with Graeme E Price:
Alan G Baer,
Amy M Cramer,
Annemarie Bodnar,
Arie C Menachem,
Atul J Agrawal,
CDR Donald Ertel,
Christine A Harman, PhD,
Dan Grabicki,
Daniel J Grabicki,
David E Bailey,
Donald C Obenhuber, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Emest F Bizjak,
Frederick F Razzaghi,
Gene D Arcy,
Graeme Price,
Gregory Price,
Hoda N Abadeer,
Jacqueline Mdiaz Albertini,
Joy Rkozlowski Klena,
Kathleen M Jordan,
Kristy A Zielny,
Kristy E Zuroski,
Laurel A Beer,
Lauren N Barber,
Lily Y Koo,
Megan A Haggerty,
Michael Havert, PhD,
Michael Serrano,
Michael Shanks, MS,
Monica Commerford, PhD,
Nirjal Bhattarai,
Patricia F Hughes, PhD,
Paul L Bellamy,
Phillip C Thai,
Phillip Thai,
Robert J Martin,
Sarah Forney,
Scott T Ballard,
Sean R Marcsisin,
Takele H Argaw,
Thai D Truong,
Thuy T Nguyen, LCDR,
Tiffany M Lucas,
Viviana R Ramirez,
Wei Wang, PhD,
Zainab Y Mansaray Storms,
Zhaohui Ye,
Zhongren Wu
Graeme E Price's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2017 | FDA 483 | KITE PHARMA, INC. - Form 483, 2017-06-16 |
May, 2023 | FDA 483 | Bristol-Myers Squibb Company - Form 483, 2023-05-05 |
June, 2017 | EIR | KITE PHARMA, INC. - EIR, 2017-10-18 |
June, 2017 | FDA 483 Response | KITE PHARMA, INC. - Form 483R, 2017-06-29 |
September, 2023 | FDA 483 | Minaris Regenerative Medicine, LLC - Form 483, 2023-09-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more